Immatics

(NASDAQ) IMTX

Current Price$9.51

Market Cap$1.28B

Since IPO (2018)-1%

5 Year-20%

1 Year+74%

1 Month-15%

Immatics Financials at a Glance

Market Cap

$1.28B

Revenue (TTM)

€37.30M

Net Income (TTM)

-€214.41M

EPS (TTM)

-$1.97

P/E Ratio

-4.83

Dividend

$0.00

Beta (Volatility)

1.01 (Average)

Dividend

$0.00

Beta (Volatility)

1.01 (Average)

Price

$9.51

Volume

228,260

Open

$9.33

Price

$9.51

Volume

228,260

Open

$9.33

Previous Close

$9.52

Daily Range

$9.27 - $9.73

52-Week Range

$5.05 - $12.41

Estimated Earnings Date

Aug 12, 2026

Dividend

$0.00

Beta (Volatility)

1.01 (Average)

Price

$9.51

Volume

228,260

Open

$9.33

Previous Close

$9.52

Daily Range

$9.27 - $9.73

52-Week Range

$5.05 - $12.41

Estimated Earnings Date

Aug 12, 2026

IMTX News

Why Immatics Stock Is Soaring Today

Keith SpeightsMay 2, 2023

Why Immatics Stock Is Soaring Today

Prosper Junior BakinyMar 17, 2021

IMTX: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Immatics

Industry

Biotechnology

Sector

Health Care

Employees

407

CEO

Harpreet Singh-Jasuja, PhD

Website

www.immatics.com

Headquarters

Tübingen, 72076, DE

IMTX Financials

Key Financial Metrics (TTM)

Gross Margin

100.00%

Operating Margin

-570.30%

Net Income Margin

-574.86%

Return on Equity

-45.27%

Return on Capital

-36.44%

Return on Assets

-39.42%

Earnings Yield

-20.70%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$1.28B

Shares Outstanding

134.10M

Volume

228.26K

Avg. Volume

452.94K

Financials (TTM)

Gross Profit

€37.30M

Operating Income

-€212.71M

EBITDA

-€202.40M

Operating Cash Flow

-€184.13M

Capital Expenditure

-€4.36M

Free Cash Flow

-€188.49M

Cash & ST Invst.

€454.04M

Total Debt

€15.10M

Immatics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q1 2026YOY CHG

Revenue

€7.61M

-59.0%

Gross Profit

€7.61M

-59.0%

Gross Margin

100.00%

N/A

Market Cap

$1.28B

N/A

Market Cap/Employee

$2.31M

N/A

Employees

554

N/A

Net Income

-€57.81M

-45.1%

EBITDA

-€54.78M

-46.2%

Quarterly Fundamentals

Name

Q1 2026YOY CHG

Total Cash

€454.04M

-16.5%

Total Debt

€15.10M

-17.9%

Accounts Receivable

€4.82M

-26.7%

Inventory

€0.00

N/A

Long Term Debt

€12.49M

-18.6%

Short Term Debt

€2.61M

-14.4%

Return on Assets

-39.42%

N/A

Return on Invested Capital

-43.54%

N/A

Free Cash Flow

-€43.51M

-16.5%

Operating Cash Flow

-€42.73M

-24.9%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

NKTRNektar Therapeutics

NKTRNektar Therapeutics$63.65+2.61%

TRMLTourmaline Bio, Inc.

TRMLTourmaline Bio, Inc.$47.98+0.00%

INBXInhibrx Biosciences Inc.

INBXInhibrx Biosciences Inc.$94.81-0.52%

CVACCureVac N.V.

CVACCureVac N.V.$4.66+0.00%

PGENPrecigen, Inc.

PGENPrecigen, Inc.$5.86+6.16%

SNDXSyndax Pharmaceuticals, Inc.

SNDXSyndax Pharmaceuticals, Inc.$21.31+7.57%

ATAIAtai Beckley Inc.

ATAIAtai Beckley Inc.$5.29+15.50%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

AALAmerican Airlines Group

AALAmerican Airlines Group$17.87+0.02%

KEELKeel Infrastructure

KEELKeel Infrastructure$6.03+0.03%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.67+0.04%

TAT&T

TAT&T$22.72+0.01%

WENWendy's

WENWendy's$7.80+0.06%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$71.83-0.04%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$41.31+0.05%

Questions About IMTX

What is the current price of Immatics?

Immatics is trading at $9.52 per share.

What is the 52-week range for Immatics?

Over the past 52 weeks, Immatics has traded between $5.05 and $12.41.

How much debt does Immatics have?

As of the most recent reporting period, Immatics reported total debt of €17.38M.

How much cash does Immatics have on hand?

Immatics reported €347.19M in cash and cash equivalents in its most recent financial results.

What is Immatics’s dividend yield?

Immatics does not currently have a dividend yield.

Immatics

Immatics Financials at a Glance

IMTX News

Why Immatics Stock Is Soaring Today

Why Immatics Stock Is Soaring Today

IMTX: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Immatics

IMTX Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Immatics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About IMTX

What is the current price of Immatics?

What is the 52-week range for Immatics?

How much debt does Immatics have?

How much cash does Immatics have on hand?

What is Immatics’s dividend yield?

Premium Investing Services